Pricing Log in Create free account

Eiger BioPharmaceuticals, Inc. (EIGRQ) vs Valion Bio, Inc. (VBIO)

Eiger BioPharmaceuticals, Inc. and Valion Bio, Inc. are both Biotechnology companies. Eiger BioPharmaceuticals, Inc. and Valion Bio, Inc. are of similar size ($2.6M and $2.4M). Eiger BioPharmaceuticals, Inc. grew revenue faster over the last twelve months: 17.0% against −49.6%. Valion Bio, Inc. has the higher net margin (0.00% vs −475.3%) and the higher return on invested capital (−61.0% vs −3,674.6%). Across the 16 metrics below, Eiger BioPharmaceuticals, Inc. leads on 9 and Valion Bio, Inc. on 7.

Valuation

Metric EIGRQ VBIO Biotechnology median
P/E n/m n/m 8.50
P/S 0.80 0.33 9.71
P/B n/m 0.04 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 4.37 11.28 9.21
Earnings yield (601.00%) (15,509.47%) (33.15%)
Free cash flow yield (594.47%) (9,619.81%) (25.50%)

Profitability

Metric EIGRQ VBIO Biotechnology median
Gross margin 99.85% (58.09%) 65.16%
Operating margin (455.12%) 0.00% 0.00%
Net margin (475.26%) 0.00% 0.00%
Free cash flow margin (474.11%) 0.00% 0.00%
Return on equity (367.00%) (489.30%) (56.36%)
Return on assets (94.31%) (104.96%) (48.04%)
Return on invested capital (3,674.55%) (61.01%) 0.00%

Growth

Metric EIGRQ VBIO Biotechnology median
Revenue growth (TTM) 16.98% (49.63%) 6.02%
EPS growth (last fiscal year) 27.11% 60.16% 30.26%
Revenue growth, 5-year CAGR — 13.18% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EIGRQ VBIO Biotechnology median
Debt to equity (2.84) 0.62 0.00
Current ratio 0.71 1.11 4.72
Net debt to EBITDA (0.22) 0.79 0.96

Dividend

Metric EIGRQ VBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EIGRQ VBIO Biotechnology median
Market cap 2.55m 2.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack